{
  "molecule_name": "darolutamida",
  "wo_patents": [
    {
      "publication_number": "WO2007046332",
      "priority_date": "2005-10-17",
      "filing_date": "2006-10-16",
      "assignees": [
        "SÃ¦Â ÂªÃ¥Â¼ÂÃ¤Â¼Å¡Ã§Â¤Â¾Ã¥â€°ÂÃ¥Â·ÂÃ¨Â£Â½Ã¤Â½Å“Ã¦â€°â‚¬ MAYEKAWA MFG CO LTDJP/JPALLEXCEPTUSÃ¥Â­Â¦Ã¦Â Â¡Ã¦Â³â€¢Ã¤ÂºÂºÃ¥ÂÅ’Ã¥Â¿â€”Ã§Â¤Â¾ THE DOSHISHAJP/JPALLEXCEPTUSÃ¥Â±Â±Ã¥ÂÂ£"
      ],
      "ipc_classifications": [],
      "cpc_classifications": [],
      "family_members": [],
      "title": "ResetClose",
      "abstract": "A CO2 refrigerator that is safe, permitting simultaneous drawout of high-temperature heat source and low-temperature heat source with a temperature difference therebetween, and that attains stabilization of control thereof, realizing an enhancement of performance coefficient. There is provided a CO2 refrigerator using CO2 (carbon dioxide) as a refrigerant and having a refrigeration cycle such that compression to a supercritical zone is followed by decompression via an expansion valve to a pressu"
    },
    {
      "publication_number": "WO2015183882",
      "priority_date": null,
      "filing_date": null,
      "assignees": [],
      "ipc_classifications": [],
      "cpc_classifications": [],
      "family_members": [],
      "title": null,
      "abstract": null
    },
    {
      "publication_number": "WO2011051540",
      "priority_date": "2009-10-27",
      "filing_date": "2010-10-27",
      "assignees": [
        "SORION CORPORATIONFI/FIALLEXCEPTUSWOHLFAHRT GERDDE/FIUSONLYTÃƒâ€“RMÃƒâ€žKANGAS OLLIFI/FIU"
      ],
      "ipc_classifications": [],
      "cpc_classifications": [],
      "family_members": [],
      "title": "ResetClose",
      "abstract": "Compounds of formula (I) wherein R1 to R16, A. B and E are as defined in the claims and pharmaceutically acceptable salts and esters thereof, are disclosed. The compounds of formula (I) possess utility as tissue-selective androgen receptor modulators (SARM) and are particularly useful as medicaments in the treatment of prostate cancer and other AR dependent conditions and diseases where AR antagonism is desired."
    },
    {
      "publication_number": "WO2009011341",
      "priority_date": "2007-07-13",
      "filing_date": "2008-07-14",
      "assignees": [
        "SÃ¥ÂÆ’Ã¤Â½ÂÃ©â€¡â€˜Ã¥Â±Å¾Ã¥Â·Â¥Ã¦Â¥Â­Ã¦Â ÂªÃ¥Â¼ÂÃ¤Â¼Å¡Ã§Â¤Â¾ SENJU METAL INDUSTRY CO LTDJP/JPALLEXCEPTUSÃ¥Â·ÂÃ¥ÂË† Ã¥â€¹â€¡Ã¥ÂÂ¸ KAWAMATA YUJIJP/JPUSONLY"
      ],
      "ipc_classifications": [],
      "cpc_classifications": [],
      "family_members": [],
      "title": "ResetClose",
      "abstract": "Disclosed is an Sn-Ag-Cu-Bi lead-free solder having excellent heat cycle resistance and mechanical strength, which can be used for soldering of an in-vehicle electronic circuit. The solder comprises the following components: Ag: 2.8-4 mass%, Bi: 1.5-6 mass% and Cu: 0.8-1.2 mass%, with the remainder being Sn."
    },
    {
      "publication_number": "WO2016179517",
      "priority_date": null,
      "filing_date": null,
      "assignees": [],
      "ipc_classifications": [],
      "cpc_classifications": [],
      "family_members": [],
      "title": null,
      "abstract": null
    },
    {
      "publication_number": "WO2017216772",
      "priority_date": null,
      "filing_date": null,
      "assignees": [],
      "ipc_classifications": [],
      "cpc_classifications": [],
      "family_members": [],
      "title": null,
      "abstract": null
    },
    {
      "publication_number": "WO2018044817",
      "priority_date": null,
      "filing_date": null,
      "assignees": [],
      "ipc_classifications": [],
      "cpc_classifications": [],
      "family_members": [],
      "title": null,
      "abstract": null
    },
    {
      "publication_number": "WO2014083512",
      "priority_date": null,
      "filing_date": null,
      "assignees": [],
      "ipc_classifications": [],
      "cpc_classifications": [],
      "family_members": [],
      "title": null,
      "abstract": null
    },
    {
      "publication_number": "WO2019200156",
      "priority_date": null,
      "filing_date": null,
      "assignees": [],
      "ipc_classifications": [],
      "cpc_classifications": [],
      "family_members": [],
      "title": null,
      "abstract": null
    },
    {
      "publication_number": "WO2019204609",
      "priority_date": null,
      "filing_date": null,
      "assignees": [],
      "ipc_classifications": [],
      "cpc_classifications": [],
      "family_members": [],
      "title": null,
      "abstract": null
    },
    {
      "publication_number": "WO2005000794",
      "priority_date": "2003-06-27",
      "filing_date": "2004-06-24",
      "assignees": [
        "SORION CORPORATIONFI/FIALLEXCEPTUSRATILAINEN JARIFI/FIUSONLYMOILANEN ANUFI/FIUSON"
      ],
      "ipc_classifications": [],
      "cpc_classifications": [],
      "family_members": [],
      "title": "ResetClose",
      "abstract": "Compounds of formula (I) wherein R1 to R4, X and A are as defined in the claims and pharmaceutically acceptable salts and esters thereof, are disclosed. The compounds of formula (I) possess utility as tissue-selective androgen receptor modulators (SARM) and are useful in hormonal therapy, e.g. in the treatment or prevention of male hypogonadism and age-related conditions such as andropause."
    },
    {
      "publication_number": "WO2013079174",
      "priority_date": "2011-11-28",
      "filing_date": null,
      "assignees": [
        "SMERCK PATENT GMBHDE/DE"
      ],
      "ipc_classifications": [],
      "cpc_classifications": [],
      "family_members": [],
      "title": "ResetClose",
      "abstract": "The present application relates to anti-PD-L1 antibodies or antigen binding fragments thereof, nucleic acid encoding the same, therapeutic compositions thereof, and their use to enhance T-cell function to upregulate cell-mediated immune responses and for the treatment of T cell dysfunctional disorders, such as tumor immunity, for the treatment of and cancer."
    },
    {
      "publication_number": "WO2014113260",
      "priority_date": null,
      "filing_date": null,
      "assignees": [],
      "ipc_classifications": [],
      "cpc_classifications": [],
      "family_members": [],
      "title": null,
      "abstract": null
    },
    {
      "publication_number": "WO2020232119",
      "priority_date": null,
      "filing_date": null,
      "assignees": [],
      "ipc_classifications": [],
      "cpc_classifications": [],
      "family_members": [],
      "title": null,
      "abstract": null
    },
    {
      "publication_number": "WO2021061644",
      "priority_date": null,
      "filing_date": null,
      "assignees": [],
      "ipc_classifications": [],
      "cpc_classifications": [],
      "family_members": [],
      "title": null,
      "abstract": null
    },
    {
      "publication_number": "WO2014043763",
      "priority_date": "2012-09-20",
      "filing_date": null,
      "assignees": [
        "STHE CHINESE UNIVERSITY OF HONG KONGCN/CNCHIU ROSSA WAI KWUNAU/CNTT"
      ],
      "ipc_classifications": [],
      "cpc_classifications": [],
      "family_members": [],
      "title": "ResetClose",
      "abstract": "Systems, methods, and apparatuses can determine and use methylation profiles of various tissues and samples. Examples are provided. A methylation profile can be deduced for fetal/tumor tissue based on a comparison of plasma methylation (or other sample with cell-free DNA) to a methylation profile of the mother/patient. A methylation profile can be determined for fetal/tumor tissue using tissue-specific alleles to identify DNA from the fetus/tumor when the sample has a mixture of DNA. A methylati"
    },
    {
      "publication_number": "WO2022013610",
      "priority_date": null,
      "filing_date": null,
      "assignees": [],
      "ipc_classifications": [],
      "cpc_classifications": [],
      "family_members": [],
      "title": null,
      "abstract": null
    },
    {
      "publication_number": "WO2022034504",
      "priority_date": null,
      "filing_date": null,
      "assignees": [],
      "ipc_classifications": [],
      "cpc_classifications": [],
      "family_members": [],
      "title": null,
      "abstract": null
    },
    {
      "publication_number": "WO2023199677",
      "priority_date": null,
      "filing_date": null,
      "assignees": [],
      "ipc_classifications": [],
      "cpc_classifications": [],
      "family_members": [],
      "title": null,
      "abstract": null
    },
    {
      "publication_number": "WO2022109487",
      "priority_date": null,
      "filing_date": null,
      "assignees": [],
      "ipc_classifications": [],
      "cpc_classifications": [],
      "family_members": [],
      "title": null,
      "abstract": null
    },
    {
      "publication_number": "WO2022109485",
      "priority_date": null,
      "filing_date": null,
      "assignees": [],
      "ipc_classifications": [],
      "cpc_classifications": [],
      "family_members": [],
      "title": null,
      "abstract": null
    },
    {
      "publication_number": "WO2022125969",
      "priority_date": null,
      "filing_date": null,
      "assignees": [],
      "ipc_classifications": [],
      "cpc_classifications": [],
      "family_members": [],
      "title": null,
      "abstract": null
    },
    {
      "publication_number": "WO2020118252",
      "priority_date": null,
      "filing_date": null,
      "assignees": [],
      "ipc_classifications": [],
      "cpc_classifications": [],
      "family_members": [],
      "title": null,
      "abstract": null
    },
    {
      "publication_number": "WO2022140339",
      "priority_date": null,
      "filing_date": null,
      "assignees": [],
      "ipc_classifications": [],
      "cpc_classifications": [],
      "family_members": [],
      "title": null,
      "abstract": null
    },
    {
      "publication_number": "WO2006034488",
      "priority_date": "2004-09-23",
      "filing_date": "2005-09-22",
      "assignees": [
        "SGENENTECH INCUS/USALLEXCEPTUSEIGENBROT CHARLES WUS/USUSONLYJUNUTULA JAGATH REDDYI"
      ],
      "ipc_classifications": [],
      "cpc_classifications": [],
      "family_members": [],
      "title": "ResetClose",
      "abstract": "Antibodies are engineered by replacing one or more amino acids of a parent antibody with non cross-linked, highly reactive cysteine amino acids. Antibody fragments may also be engineered with one or more cysteine amino acids to form cysteine engineered antibody fragments (ThioFab). Methods of design, preparation, screening, and selection of the cysteine engineered antibodies are provided. Cysteine engineered antibodies (Ab), optionally with an albumin-binding peptide (ABP) sequence, are conjugat"
    },
    {
      "publication_number": "WO2022188856",
      "priority_date": null,
      "filing_date": null,
      "assignees": [],
      "ipc_classifications": [],
      "cpc_classifications": [],
      "family_members": [],
      "title": null,
      "abstract": null
    },
    {
      "publication_number": "WO2021154893",
      "priority_date": null,
      "filing_date": null,
      "assignees": [],
      "ipc_classifications": [],
      "cpc_classifications": [],
      "family_members": [],
      "title": null,
      "abstract": null
    },
    {
      "publication_number": "WO2014152588",
      "priority_date": null,
      "filing_date": null,
      "assignees": [],
      "ipc_classifications": [],
      "cpc_classifications": [],
      "family_members": [],
      "title": null,
      "abstract": null
    },
    {
      "publication_number": "WO2022235585",
      "priority_date": null,
      "filing_date": null,
      "assignees": [],
      "ipc_classifications": [],
      "cpc_classifications": [],
      "family_members": [],
      "title": null,
      "abstract": null
    },
    {
      "publication_number": "WO2022249089",
      "priority_date": null,
      "filing_date": null,
      "assignees": [],
      "ipc_classifications": [],
      "cpc_classifications": [],
      "family_members": [],
      "title": null,
      "abstract": null
    },
    {
      "publication_number": "WO2022258975",
      "priority_date": null,
      "filing_date": null,
      "assignees": [],
      "ipc_classifications": [],
      "cpc_classifications": [],
      "family_members": [],
      "title": null,
      "abstract": null
    },
    {
      "publication_number": "WO2020205919",
      "priority_date": null,
      "filing_date": null,
      "assignees": [],
      "ipc_classifications": [],
      "cpc_classifications": [],
      "family_members": [],
      "title": null,
      "abstract": null
    },
    {
      "publication_number": "WO2008110611",
      "priority_date": "2007-03-15",
      "filing_date": "2008-03-13",
      "assignees": [
        "SNOVARTIS AGCH/CHALLEXCEPTUSDAI MIAOCN/CNUSONLYHE FENGCN/CNUSONLYJAIN RISHI KUM"
      ],
      "ipc_classifications": [],
      "cpc_classifications": [],
      "family_members": [],
      "title": "ResetClose",
      "abstract": "The present disclosure relates to compounds relating to the diagnosis and treatment of pathologies relating to the Hedgehog pathway, including but not limited to tumor formation, cancer, neoplasia, and non-malignant hyperproliferative disorders; specifically relating to compounds of formula (I)."
    },
    {
      "publication_number": "WO2017030814",
      "priority_date": null,
      "filing_date": null,
      "assignees": [],
      "ipc_classifications": [],
      "cpc_classifications": [],
      "family_members": [],
      "title": null,
      "abstract": null
    },
    {
      "publication_number": "WO2016206540",
      "priority_date": null,
      "filing_date": null,
      "assignees": [],
      "ipc_classifications": [],
      "cpc_classifications": [],
      "family_members": [],
      "title": null,
      "abstract": null
    },
    {
      "publication_number": "WO2022188665",
      "priority_date": null,
      "filing_date": null,
      "assignees": [],
      "ipc_classifications": [],
      "cpc_classifications": [],
      "family_members": [],
      "title": null,
      "abstract": null
    },
    {
      "publication_number": "WO2019166385",
      "priority_date": null,
      "filing_date": null,
      "assignees": [],
      "ipc_classifications": [],
      "cpc_classifications": [],
      "family_members": [],
      "title": null,
      "abstract": null
    },
    {
      "publication_number": "WO2023093640",
      "priority_date": null,
      "filing_date": null,
      "assignees": [],
      "ipc_classifications": [],
      "cpc_classifications": [],
      "family_members": [],
      "title": null,
      "abstract": null
    },
    {
      "publication_number": "WO2023222557",
      "priority_date": null,
      "filing_date": null,
      "assignees": [],
      "ipc_classifications": [],
      "cpc_classifications": [],
      "family_members": [],
      "title": null,
      "abstract": null
    },
    {
      "publication_number": "WO2020169538",
      "priority_date": null,
      "filing_date": null,
      "assignees": [],
      "ipc_classifications": [],
      "cpc_classifications": [],
      "family_members": [],
      "title": null,
      "abstract": null
    },
    {
      "publication_number": "WO2021061642",
      "priority_date": null,
      "filing_date": null,
      "assignees": [],
      "ipc_classifications": [],
      "cpc_classifications": [],
      "family_members": [],
      "title": null,
      "abstract": null
    },
    {
      "publication_number": "WO2022246179",
      "priority_date": null,
      "filing_date": null,
      "assignees": [],
      "ipc_classifications": [],
      "cpc_classifications": [],
      "family_members": [],
      "title": null,
      "abstract": null
    }
  ],
  "br_patents": [
    {
      "publication_number": "BR112016027624A2",
      "wo_related": "WO2015183882",
      "title": "Nanoparticle Drug Conjugate (ndc)",
      "filing_date": "2015-05-27",
      "publication_date": "2017-08-15",
      "legal_status": "Active",
      "patent_type": "Unknown"
    },
    {
      "publication_number": "BR112016027624A8",
      "wo_related": "WO2015183882",
      "title": "nanoparticle drug conjugate (ndc)",
      "filing_date": "2015-05-27",
      "publication_date": "2021-07-20",
      "legal_status": "Abandoned",
      "patent_type": "Product"
    },
    {
      "publication_number": "BR112017023849A2",
      "wo_related": "WO2016179517",
      "title": "anti-ox40 antibodies and methods of use",
      "filing_date": "2016-05-06",
      "publication_date": "2018-07-17",
      "legal_status": "Active",
      "patent_type": "Use"
    },
    {
      "publication_number": "BR112021022008A2",
      "wo_related": "WO2020232119",
      "title": "Anticancer nuclear hormone receptor targeting compounds",
      "filing_date": "2020-05-13",
      "publication_date": "2022-05-17",
      "legal_status": "Active",
      "patent_type": "Product"
    },
    {
      "publication_number": "BR112023000763A2",
      "wo_related": "WO2022013610",
      "title": "PHARMACEUTICAL COMPOSITION, METHOD FOR PREPARING 177LU-PSMA I&T, METHOD FOR Ã¢â‚¬Â¦",
      "filing_date": "2021-07-13",
      "publication_date": "2023-03-21",
      "legal_status": "Active",
      "patent_type": "Formulation"
    },
    {
      "publication_number": "BR112023002295A2",
      "wo_related": "WO2022034504",
      "title": "COMBINATION THERAPY",
      "filing_date": "2021-08-10",
      "publication_date": "2023-03-14",
      "legal_status": "Active",
      "patent_type": "Formulation"
    },
    {
      "publication_number": "BR112023018204A2",
      "wo_related": "WO2022188856",
      "title": "DISEASE TREATMENT METHOD USING GREMLIN1 ANTAGONISTS",
      "filing_date": "2022-03-11",
      "publication_date": "2023-10-24",
      "legal_status": "Active",
      "patent_type": "Use"
    }
  ],
  "metadata": {
    "molecule_name": {
      "atc_codes": [],
      "structure_3d_url": "https://pubchem.ncbi.nlm.nih.gov/compound/67171867#section=3D-Conformer",
      "pubchem_cid": 67171867,
      "inn_name": "Darolutamide",
      "molecular_weight": "398.8",
      "development_codes": [
        "DA-56387",
        "DB12941",
        "FD161413",
        "NSC825331",
        "AC-32628",
        "CS-5174",
        "NSC-825331",
        "ODM-201",
        "GTPL10439",
        "BDBM309979",
        "AS-75032",
        "HY-16985",
        "ODM201",
        "CCG-268640"
      ],
      "generic_name": "DAROLUTAMIDE",
      "synonyms": [
        "1297538-32-9",
        "1H-Pyrazole-3-carboxamide, N-[(1S)-2-[3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl]-1-methylethyl]-5-(1-hydroxyethyl)-",
        "BLIJXOOIHRSQRB-PXYINDEMSA-N",
        "N-((2S)-1-(3-(3-chloro-4-cyanophenyl)pyrazol-1-yl)propan-2-yl)-5-(1-hydroxyethyl)-1H-pyrazole-3-carboxamide",
        "DTXCID001513521",
        "DTXSID101027953",
        "Darolutamide (ODM-201)",
        "N-[(1S)-2-[3-(3-Chloro-4-cyanophenyl)-1H-pyrazol-1-yl]-1-methylethyl]-5-(1-hydroxyethyl)-1H-pyrazole-3-carboxamide; BAY 1841788; ODM-201",
        "MFCD29472270",
        "DAROLUTAMIDE [JAN]",
        "BAY1841788",
        "ODM-201(Darolutamide)?",
        "ODM-201;BAY-1841788",
        "Darolutamide [USAN]",
        "SCHEMBL1814935",
        "X05U0N2RCO",
        "CHEMBL4297185",
        "DAROLUTAMIDE [WHO-DD]",
        "Darolutamide (JAN/USAN/INN)",
        "DAROLUTAMIDE [INN]",
        "UNII-X05U0N2RCO",
        "N-((S)-1-(3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl)-propan-2-yl)-3-(1-hydroxyethyl)-1H-pyrazole-5-carboxamide",
        "C19H19ClN6O2",
        "Darolutamide (Standard)",
        "SCHEMBL13733117",
        "Darolutamide",
        "Antiandrogen ODM-201",
        "darolutamidum",
        "SCHEMBL29390245",
        "1H-Pyrazole-3-carboxamide, N-((1S)-2-(3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl)-1-methylethyl)-5-(1-hydroxyethyl)-",
        "Odm-201",
        "Nebeqa (TN)",
        "N-((2S)-1-(3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl)propan-2-yl)-5-((1RS)-1-hydroxyethyl)-1H-pyrazole-3-carboxamide",
        "N-[(2S)-1-[3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl]propan-2-yl]-5-(1-hydroxyethyl)-1H-pyrazole-3-carboxamide",
        "Darolutamida",
        "N-[(2S)-1-[3-(3-chloro-4-cyanophenyl)pyrazol-1-yl]propan-2-yl]-5-(1-hydroxyethyl)-1H-pyrazole-3-carboxamide",
        "ODM201",
        "darolutamida",
        "BAY-1841788",
        "N-((1S)-2-(3-(3-Chloro-4-cyanophenyl)-1H-pyrazol-1-yl)-1-methylethyl)-5-(1-hydroxyethyl)-1H-pyrazole-3-carboxamide",
        "N-((S)-1-(3-(3-Chloro-4-cyanophenyl)-1H-pyrazol-1-yl)propan-2-yl)-5-(1-hydroxyethyl)-1H-pyrazole-3-carboxamide",
        "orb1300350",
        "RefChem:58141",
        "Nubeqa",
        "BAY 1841788",
        "L02BB06",
        "ODM-201",
        "N-[(1S)-2-[3-(3-chloro-4-cyano-phenyl)pyrazol-1-yl]-1-methyl-ethyl]-5-(1-hydroxyethyl)-1H-pyrazole-3-carboxamide",
        "DAROLUTAMIDE [MI]",
        "GTPL10439",
        "EX-A759",
        "N-((2S)-1-(3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl)propan-2-yl)-5-(1-hydroxyethyl)-1H-pyrazole-3-carboxamide"
      ],
      "mechanism_of_action": null,
      "therapeutic_class": null,
      "chembl_id": "CHEMBL4297185",
      "structure_2d_url": "https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?cid=67171867&t=l",
      "known_br_numbers": [],
      "market_status": "Unknown",
      "drugbank_id": null,
      "market_value_usd": null,
      "first_approval_year": 2019,
      "inchi": "InChI=1S/C19H19ClN6O2/c1-11(22-19(28)18-8-17(12(2)27)23-24-18)10-26-6-5-16(25-26)13-3-4-14(9-21)15(20)7-13/h3-8,11-12,27H,10H2,1-2H3,(H,22,28)(H,23,24)/t11-,12?/m0/s1",
      "known_wo_numbers": [],
      "molecule_name": "darolutamida",
      "smiles": null,
      "iupac_name": "N-[(2S)-1-[3-(3-chloro-4-cyanophenyl)pyrazol-1-yl]propan-2-yl]-5-(1-hydroxyethyl)-1H-pyrazole-3-carboxamide",
      "cas_numbers": [
        "1297538-32-9"
      ],
      "commercial_name": "Darolutamide",
      "molecular_formula": "C19H19ClN6O2",
      "wo_numbers": [
        "WO2005000794",
        "WO2006034488",
        "WO2007046332",
        "WO2008110611",
        "WO2009011341",
        "WO2011051540",
        "WO2013079174",
        "WO2014043763",
        "WO2014083512",
        "WO2014113260",
        "WO2014152588",
        "WO2015183882",
        "WO2016058080A1",
        "WO2016179517",
        "WO2016206540",
        "WO2017030814",
        "WO2017216772",
        "WO2018044817",
        "WO2019166385",
        "WO2019200156",
        "WO2019204609",
        "WO2020118252",
        "WO2020169538",
        "WO2020205919",
        "WO2020232119",
        "WO2021061642",
        "WO2021061644",
        "WO2021154893",
        "WO2022013610",
        "WO2022034504",
        "WO2022109485",
        "WO2022109487",
        "WO2022125969",
        "WO2022140339",
        "WO2022188665",
        "WO2022188856",
        "WO2022235585",
        "WO2022246179",
        "WO2022249089",
        "WO2022258975",
        "WO2023093640",
        "WO2023199677",
        "WO2023222557"
      ],
      "inchi_key": "BLIJXOOIHRSQRB-PXYINDEMSA-N"
    },
    "search_timestamp": "2025-11-26T21:30:37.078686",
    "version": "Pharmyrus v31.0-UNIFIED-v2",
    "generated_at": "2026-01-02T02:29:40.581273",
    "total_wo_patents": 43,
    "total_national_patents": 51
  },
  "statistics": {
    "total_wo_patents": 43,
    "wo_with_national_patents": 42,
    "wo_without_national_patents": 1,
    "wo_with_br_patents": 6,
    "patents_without_wo": 55,
    "total_unique_jurisdictions": 9
  },
  "predictive_intelligence": {
    "layer_version": "v31.0-PREDICTIVE",
    "methodology": "Legally Defensible PCT Timeline Analysis",
    "generated_at": "2026-01-11T17:07:55.838473",
    "summary": {
      "total_wo_analyzed": 42,
      "wos_with_found_br": 6,
      "wos_without_br": 36,
      "predicted_br_filings": 8,
      "high_confidence_predictions": 0
    },
    "predicted_br_patents": [
      {
        "wo_number": "WO2007046332",
        "publication_number": null,
        "patent_status": {
          "type": "predicted",
          "certainty_level": "ainda_nao_existente",
          "confidence_score": 0.05
        },
        "inference_details": {
          "reasoning": "Prazo de 30 meses expirado - filing não realizado",
          "pct_timeline": {
            "priority_date": "2005-10-17",
            "national_phase_deadline": "2008-04-04",
            "days_remaining": -6492,
            "deadline_status": "expired"
          },
          "applicant_analysis": {
            "name": "SÃ¦Â ÂªÃ¥Â¼ÂÃ¤Â¼Å¡Ã§Â¤Â¾Ã¥â€°ÂÃ¥Â·ÂÃ¨Â£Â½Ã¤Â½Å“Ã¦â€°â‚¬ MAYEKAWA MFG CO LTDJP/JPALLEXCEPTUSÃ¥Â­Â¦Ã¦Â Â¡Ã¦Â³â€¢Ã¤ÂºÂºÃ¥ÂÅ’Ã¥Â¿â€”Ã§Â¤Â¾ THE DOSHISHAJP/JPALLEXCEPTUSÃ¥Â±Â±Ã¥ÂÂ£",
            "historical_br_filing_rate": 0.5,
            "pattern": "sometimes_files_brazil"
          },
          "pct_designation": {
            "brazil_designated": true,
            "family_size": 0
          },
          "market_relevance": {
            "therapeutic_area": null,
            "ipc_classifications": []
          },
          "model_prediction": {
            "filing_probability": 0.25,
            "model_type": "hybrid_rule_based_ml"
          }
        },
        "provenance": {
          "data_sources": [
            "WIPO_PATENTSCOPE",
            "APPLICANT_HISTORICAL_MODEL",
            "PCT_DESIGNATION"
          ],
          "last_verified": "2026-01-11",
          "methodology_version": "v31.0-PREDICTIVE",
          "legally_defensible": true
        }
      },
      {
        "wo_number": "WO2011051540",
        "publication_number": null,
        "patent_status": {
          "type": "predicted",
          "certainty_level": "ainda_nao_existente",
          "confidence_score": 0.05
        },
        "inference_details": {
          "reasoning": "Prazo de 30 meses expirado - filing não realizado",
          "pct_timeline": {
            "priority_date": "2009-10-27",
            "national_phase_deadline": "2012-04-14",
            "days_remaining": -5021,
            "deadline_status": "expired"
          },
          "applicant_analysis": {
            "name": "SORION CORPORATIONFI/FIALLEXCEPTUSWOHLFAHRT GERDDE/FIUSONLYTÃƒâ€“RMÃƒâ€žKANGAS OLLIFI/FIU",
            "historical_br_filing_rate": 0.93,
            "pattern": "always_files_brazil"
          },
          "pct_designation": {
            "brazil_designated": true,
            "family_size": 0
          },
          "market_relevance": {
            "therapeutic_area": null,
            "ipc_classifications": []
          },
          "model_prediction": {
            "filing_probability": 0.465,
            "model_type": "hybrid_rule_based_ml"
          }
        },
        "provenance": {
          "data_sources": [
            "WIPO_PATENTSCOPE",
            "APPLICANT_HISTORICAL_MODEL",
            "PCT_DESIGNATION"
          ],
          "last_verified": "2026-01-11",
          "methodology_version": "v31.0-PREDICTIVE",
          "legally_defensible": true
        }
      },
      {
        "wo_number": "WO2009011341",
        "publication_number": null,
        "patent_status": {
          "type": "predicted",
          "certainty_level": "ainda_nao_existente",
          "confidence_score": 0.05
        },
        "inference_details": {
          "reasoning": "Prazo de 30 meses expirado - filing não realizado",
          "pct_timeline": {
            "priority_date": "2007-07-13",
            "national_phase_deadline": "2009-12-29",
            "days_remaining": -5858,
            "deadline_status": "expired"
          },
          "applicant_analysis": {
            "name": "SÃ¥ÂÆ’Ã¤Â½ÂÃ©â€¡â€˜Ã¥Â±Å¾Ã¥Â·Â¥Ã¦Â¥Â­Ã¦Â ÂªÃ¥Â¼ÂÃ¤Â¼Å¡Ã§Â¤Â¾ SENJU METAL INDUSTRY CO LTDJP/JPALLEXCEPTUSÃ¥Â·ÂÃ¥ÂË† Ã¥â€¹â€¡Ã¥ÂÂ¸ KAWAMATA YUJIJP/JPUSONLY",
            "historical_br_filing_rate": 0.5,
            "pattern": "sometimes_files_brazil"
          },
          "pct_designation": {
            "brazil_designated": true,
            "family_size": 0
          },
          "market_relevance": {
            "therapeutic_area": null,
            "ipc_classifications": []
          },
          "model_prediction": {
            "filing_probability": 0.25,
            "model_type": "hybrid_rule_based_ml"
          }
        },
        "provenance": {
          "data_sources": [
            "WIPO_PATENTSCOPE",
            "APPLICANT_HISTORICAL_MODEL",
            "PCT_DESIGNATION"
          ],
          "last_verified": "2026-01-11",
          "methodology_version": "v31.0-PREDICTIVE",
          "legally_defensible": true
        }
      },
      {
        "wo_number": "WO2005000794",
        "publication_number": null,
        "patent_status": {
          "type": "predicted",
          "certainty_level": "ainda_nao_existente",
          "confidence_score": 0.05
        },
        "inference_details": {
          "reasoning": "Prazo de 30 meses expirado - filing não realizado",
          "pct_timeline": {
            "priority_date": "2003-06-27",
            "national_phase_deadline": "2005-12-13",
            "days_remaining": -7335,
            "deadline_status": "expired"
          },
          "applicant_analysis": {
            "name": "SORION CORPORATIONFI/FIALLEXCEPTUSRATILAINEN JARIFI/FIUSONLYMOILANEN ANUFI/FIUSON",
            "historical_br_filing_rate": 0.93,
            "pattern": "always_files_brazil"
          },
          "pct_designation": {
            "brazil_designated": true,
            "family_size": 0
          },
          "market_relevance": {
            "therapeutic_area": null,
            "ipc_classifications": []
          },
          "model_prediction": {
            "filing_probability": 0.465,
            "model_type": "hybrid_rule_based_ml"
          }
        },
        "provenance": {
          "data_sources": [
            "WIPO_PATENTSCOPE",
            "APPLICANT_HISTORICAL_MODEL",
            "PCT_DESIGNATION"
          ],
          "last_verified": "2026-01-11",
          "methodology_version": "v31.0-PREDICTIVE",
          "legally_defensible": true
        }
      },
      {
        "wo_number": "WO2013079174",
        "publication_number": null,
        "patent_status": {
          "type": "predicted",
          "certainty_level": "ainda_nao_existente",
          "confidence_score": 0.05
        },
        "inference_details": {
          "reasoning": "Prazo de 30 meses expirado - filing não realizado",
          "pct_timeline": {
            "priority_date": "2011-11-28",
            "national_phase_deadline": "2014-05-16",
            "days_remaining": -4259,
            "deadline_status": "expired"
          },
          "applicant_analysis": {
            "name": "SMERCK PATENT GMBHDE/DE",
            "historical_br_filing_rate": 0.9,
            "pattern": "always_files_brazil"
          },
          "pct_designation": {
            "brazil_designated": true,
            "family_size": 0
          },
          "market_relevance": {
            "therapeutic_area": null,
            "ipc_classifications": []
          },
          "model_prediction": {
            "filing_probability": 0.45,
            "model_type": "hybrid_rule_based_ml"
          }
        },
        "provenance": {
          "data_sources": [
            "WIPO_PATENTSCOPE",
            "APPLICANT_HISTORICAL_MODEL",
            "PCT_DESIGNATION"
          ],
          "last_verified": "2026-01-11",
          "methodology_version": "v31.0-PREDICTIVE",
          "legally_defensible": true
        }
      },
      {
        "wo_number": "WO2014043763",
        "publication_number": null,
        "patent_status": {
          "type": "predicted",
          "certainty_level": "ainda_nao_existente",
          "confidence_score": 0.05
        },
        "inference_details": {
          "reasoning": "Prazo de 30 meses expirado - filing não realizado",
          "pct_timeline": {
            "priority_date": "2012-09-20",
            "national_phase_deadline": "2015-03-09",
            "days_remaining": -3962,
            "deadline_status": "expired"
          },
          "applicant_analysis": {
            "name": "STHE CHINESE UNIVERSITY OF HONG KONGCN/CNCHIU ROSSA WAI KWUNAU/CNTT",
            "historical_br_filing_rate": 0.5,
            "pattern": "sometimes_files_brazil"
          },
          "pct_designation": {
            "brazil_designated": true,
            "family_size": 0
          },
          "market_relevance": {
            "therapeutic_area": null,
            "ipc_classifications": []
          },
          "model_prediction": {
            "filing_probability": 0.25,
            "model_type": "hybrid_rule_based_ml"
          }
        },
        "provenance": {
          "data_sources": [
            "WIPO_PATENTSCOPE",
            "APPLICANT_HISTORICAL_MODEL",
            "PCT_DESIGNATION"
          ],
          "last_verified": "2026-01-11",
          "methodology_version": "v31.0-PREDICTIVE",
          "legally_defensible": true
        }
      },
      {
        "wo_number": "WO2006034488",
        "publication_number": null,
        "patent_status": {
          "type": "predicted",
          "certainty_level": "ainda_nao_existente",
          "confidence_score": 0.05
        },
        "inference_details": {
          "reasoning": "Prazo de 30 meses expirado - filing não realizado",
          "pct_timeline": {
            "priority_date": "2004-09-23",
            "national_phase_deadline": "2007-03-12",
            "days_remaining": -6881,
            "deadline_status": "expired"
          },
          "applicant_analysis": {
            "name": "SGENENTECH INCUS/USALLEXCEPTUSEIGENBROT CHARLES WUS/USUSONLYJUNUTULA JAGATH REDDYI",
            "historical_br_filing_rate": 0.5,
            "pattern": "sometimes_files_brazil"
          },
          "pct_designation": {
            "brazil_designated": true,
            "family_size": 0
          },
          "market_relevance": {
            "therapeutic_area": null,
            "ipc_classifications": []
          },
          "model_prediction": {
            "filing_probability": 0.25,
            "model_type": "hybrid_rule_based_ml"
          }
        },
        "provenance": {
          "data_sources": [
            "WIPO_PATENTSCOPE",
            "APPLICANT_HISTORICAL_MODEL",
            "PCT_DESIGNATION"
          ],
          "last_verified": "2026-01-11",
          "methodology_version": "v31.0-PREDICTIVE",
          "legally_defensible": true
        }
      },
      {
        "wo_number": "WO2008110611",
        "publication_number": null,
        "patent_status": {
          "type": "predicted",
          "certainty_level": "ainda_nao_existente",
          "confidence_score": 0.05
        },
        "inference_details": {
          "reasoning": "Prazo de 30 meses expirado - filing não realizado",
          "pct_timeline": {
            "priority_date": "2007-03-15",
            "national_phase_deadline": "2009-08-31",
            "days_remaining": -5978,
            "deadline_status": "expired"
          },
          "applicant_analysis": {
            "name": "SNOVARTIS AGCH/CHALLEXCEPTUSDAI MIAOCN/CNUSONLYHE FENGCN/CNUSONLYJAIN RISHI KUM",
            "historical_br_filing_rate": 0.95,
            "pattern": "always_files_brazil"
          },
          "pct_designation": {
            "brazil_designated": true,
            "family_size": 0
          },
          "market_relevance": {
            "therapeutic_area": null,
            "ipc_classifications": []
          },
          "model_prediction": {
            "filing_probability": 0.475,
            "model_type": "hybrid_rule_based_ml"
          }
        },
        "provenance": {
          "data_sources": [
            "WIPO_PATENTSCOPE",
            "APPLICANT_HISTORICAL_MODEL",
            "PCT_DESIGNATION"
          ],
          "last_verified": "2026-01-11",
          "methodology_version": "v31.0-PREDICTIVE",
          "legally_defensible": true
        }
      }
    ],
    "high_confidence_only": [],
    "disclaimer": "Dados marcados como 'inferido' ou 'previsto' devem ser verificados independentemente antes de uso em processos legais. Esta análise não constitui parecer jurídico. Aplicações PCT permanecem confidenciais por 18 meses após depósito."
  }
}